PUBLICATION
PEMBROLIZUMAB WITH OR WITHOUT CHEMOTHERAPY IN RECURRENT OR METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA: 5-YEAR FOLLOW-UP FROM THE RANDOMIZED PHASE III KEYNOTE-048 STUDY
Authors: Makoto Tahara, Richard Greil, Danny Rischin, Kevin J. Harrington, Barbara Burtness, Gilberto de Castro, Amanda Psyrri, Irene Braña, Prakash Neupane, Ă…se Bratland, Thorsten Fuereder, Brett G.M. Hughes, Ricard MesĂa, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Jianxin Lin, Burak Gumuscu, Nati Lerman, Denis Soulières
Date of publication: 21/04/2025
A NONINVASIVE APPROACH TO ASSESS THE PREVALENCE OF AND FACTORS ASSOCIATED WITH ANEMIA RISK IN MALAYSIAN CHILDREN UNDER THREE YEARS OF AGE: CROSS-SECTIONAL STUDY
Authors: Muhammad Yazid Jalaludin, Ho Bee Kiau, Suriati Hasim, Wai Khew Lee, Angie Low, Nik Harlina Nik Kazim, Jia Tse Hoi, Sri Wahyu Taher
Date of publication: 24/03/2025
TEMPORAL TRENDS FROM HIV DIAGNOSIS TO ART INITIATION AMONG ADULTS LIVING WITH HIV IN THE ASIA–PACIFIC (2013–2023)
Authors: Thinh Toan Vu, Dhanushi Rupasinghe, Vohith Khol, Romanee Chaiwarith, Junko Tanuma, Nagalingeswaran Kumarasamy, Suwimon Khusuwan, I Ketut Agus Somia, Sanjay Pujari, Man Po Lee, Rohidas T. Borse, Sasisopin Kiertiburanakul, Evy Yunihastuti, Iskandar Azwa, Jun Yong Choi, Hsin-Pai Chen, Rossana Ditangco, Anchalee Avihingsanon, Yasmin Gani, Jeremy Ross, Awachana Jiamsakul on behalf of IeDEA Asia-Pacific
Date of publication: 04/03/2025
PEMBROLIZUMAB (MK-3475) PLUS PLATINUM AND GEMCITABINE AS FIRST-LINE TREATMENT OF RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (PIPER): A PHASE 2, MULTICENTRE, SINGLE-ARM PROTOCOL STUDY IN MALAYSIA
Authors: Sok Ching Cheong, Bawani Selvam, Gwo Fuang Ho, Ibtisam Muhamad Nor, Chih Kiang Tan, Yoke Fui Wong, Soo Hwang Teo, Kue Peng Lim, Annie Wai Yeeng Chai, Abqariyah Yahya, Wan Zamaniah Wan Ishak
Date of publication: 03/12/2024
PATIENT-REPORTED OUTCOMES FOR PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER AND BRCA1/2 GENE ALTERATIONS: FINAL ANALYSIS FROM THE RANDOMIZED PHASE 3 MAGNITUDE TRIAL
Authors: Dana E. Rathkopf, Guilhem Roubaud, Kim N. Chi, Eleni Efstathiou, Gerhardt Attard, David Olmos, Eric J. Small, Marniza Saad, Elena Castro, Won Kim, Daphne Wu, Kristi Bertzos, Shiva Dibaj, Jenny Zhang, Peter Francis, Matthew R. Smith
Date of publication: 23/09/2024
CONTINUOUS VS INTERMITTENT Î’-LACTAM ANTIBIOTIC INFUSIONS IN CRITICALLY ILL PATIENTS WITH SEPSIS: THE BLING III RANDOMIZED CLINICAL TRIAL
Authors: Joel M. Dulhunty, Stephen J. Brett, Jan J. De Waele, Dorrilyn Rajbhandari, Laurent Billot, Menino O. Cotta, Joshua S. Davis, Simon Finfer, Naomi E. Hammond, Serena Knowles, Xiaoqiu Liu, Shay McGuinness, Jayanthi Mysore, David L. Paterson, Sandra Peake, Andrew Rhodes, Jason A. Roberts, Claire Roger, Charudatt Shirwadkar, Therese Starr, Colman Taylor, John A. Myburgh, Jeffrey Lipman
Date of publication: 27/08/2024
VITAMIN E IMPROVES SERUM MARKERS AND HISTOLOGY IN ADULTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS
Authors: Nicholas Ming-Zher Chee, Ram Prasad Sinnanaidu, Wah-Kheong Chan
Date of publication: 16/08/2024
LIVERSTAT FOR RISK STRATIFICATION FOR PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE
Authors: Yong Wen Leow, Wah Loong Chan, Lee Lee Lai, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Ronald Quiambao, Mona Munteanu, Wah Kheong Chan
Date of publication: 01/07/2024
EFFICACY AND SAFETY OF ODEVIXIBAT IN PATIENTS WITH ALAGILLE SYNDROME (ASSERT): A PHASE 3, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED TRIAL
Authors: Nadia Ovchinsky, Madeleine Aumar, Alastair Baker, Ulrich Baumann, Philip Bufler, Mara Cananzi, Piotr Czubkowski, Ă–zlem Durmaz, Ryan Fischer, Giuseppe Indolfi, Wikrom W. Karnsakul, Florence Lacaille, Way S. Lee, Giuseppe Maggiore, Philip Rosenthal, Mathias Ruiz, Etienne Sokal, Ekkehard Sturm, Wendy van der Woerd, Henkjan J. Verkade, Andrew Wehrman, Christine Clemson, Qifeng Yu, Quanhong Ni, Jessica Ruvido, Susan Manganaro, Jan P. Mattsson
Date of publication: 07/2024
CLINICAL AND ECONOMIC IMPACT OF CMV INFECTION IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: PERSPECTIVES FROM A MIDDLE-INCOME NATION
Authors: Gin Gin Gan, Thevambiga Iyadorai, Noor Yuhyi Sulaiman, Najihah Hussein, Hany Ariffin
Date of publication: 21/06/2024
SUBCUTANEOUS VERSUS INTRAVENOUS AMIVANTAMAB, BOTH IN COMBINATION WITH LAZERTINIB, IN REFRACTORY EPIDERMAL GROWTH FACTOR RECEPTOR–MUTATED NON–SMALL CELL LUNG CANCER: PRIMARY RESULTS FROM THE PHASE III PALOMA-3 STUDY
Authors: Natasha B. Leighl, Hiroaki Akamatsu, Sun Min Lim, Ying Cheng, Anna R. Minchom, Melina E. Marmarelis, Rachel E. Sanborn, James Chih-Hsin Yang, Baogang Liu, Thomas John, Bartomeu MassutĂ, Alexander I. Spira, Se-Hoon Lee, Jialei Wang, Juan Li, Caigang Liu, Silvia Novello, Masashi Kondo, Motohiro Tamiya, Ernesto Korbenfeld, Mor Moskovitz, Ji-Youn Han, Mariam Alexander, Rohit Joshi, Enriqueta Felip, Pei Jye Voon, Pongwut Danchaivijitr, Ping-Chih Hsu, Felipe JosĂ© Silva Melo Cruz, Thomas Wehler, Laurent Greillier, Encarnação Teixeira, Danny Nguyen, Joshua K. Sabari, Angel Qin, Dariusz Kowalski, Mehmet Ali Nahit Ĺžendur, John Xie, Debopriya Ghosh, Ali Alhadab, Nahor Haddish-Berhane, Pamela L. Clemens, Patricia Lorenzini, Remy B. Verheijen, Mohamed Gamil, Joshua M. Bauml, Mahadi Baig, Antonio Passaro for the PALOMA-3 Investigators
Date of publication: 10/06/2024
DOLUTEGRAVIR PLUS BOOSTED DARUNAVIR VERSUS RECOMMENDED STANDARD-OF-CARE ANTIRETROVIRAL REGIMENS IN PEOPLE WITH HIV-1 FOR WHOM RECOMMENDED FIRST-LINE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR THERAPY HAS FAILED (D2EFT): AN OPEN-LABEL, RANDOMISED, PHASE 3B/4 TRIAL
Authors: Gail Matthews, Simone Jacoby, Margaret Borok, Nnakelu Eriobu, Richard Kaplan, Nagalingeswaran Kumarasamy, Jaclyn Ann Bennet, Anchalee Avihingsanon, Ploenchan Chetchotisakd, Sandra Wagner Cardoso, Iskandar Azwa, Marcelo Losso, Dannae Brown, Dona Arlinda, Jolie Hutchinson, Anthony Kelleher, Mohamed Cisse, Sounkalo Dao, Mark Polizzotto, Sean Emery, Matthew Law, Emmanuelle Papot, Muhammad Karyana, Sergio Lupo, Ana Melisa Solari, Beatriz Grinsztejn, Marcello Wolff, Jaime Andrade-Villanueva, Juan Luis Mosqueda GĂłmez, Ting Soo Chow, Lerato Mohapi, Evy Yunihastuti, Usman Hadi, Sudirman Katu, Yanri Wijayanti Subronto, H. Clifford Lane, Leonardo Perelis
Date of publication: 21/05/2024
THE ESTABLISHMENT OF A MULTIPLE MYELOMA CLINICAL REGISTRY IN THE ASIA–PACIFIC REGION: THE ASIA–PACIFIC MYELOMA AND RELATED DISEASES REGISTRY (APAC MRDR)
Authors: Naomi Aoki, Pin-Yen Chen, Wenming Chen, Wee Joo Chng, Gin Gin Gan, Yeow Tee Goh, Jian Hou, Jeffrey Huang, Kihyun Kim, Je Jung Lee, Jin Lu, Zoe K. McQuilten, Chang Ki Min, Elizabeth Moore, Laura Oliver, Neil A. Waters, Cameron Wellard, Erica M. Wood, Su-Peng Yeh, Andrew Spencer on behalf of the APAC MRDR Investigators
Date of publication: 02/05/2024
CMV INFECTION POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN A RESOURCE LIMITED COUNTRY
Authors: Noor Yuhyi Sulaiman, Nur Adila Anuar, Normala Arshad, Chin Sum Cheong, Chee Chiat Liong, Shasha Khairullah, Edmund Fui Min Chin, Ping Chong Bee, I Ching Sam, Thevambiga Iyadorai, Gin Gin Gan
Date of publication: 20/04/2024
AMIVANTAMAB PLUS CHEMOTHERAPY WITH AND WITHOUT LAZERTINIB IN EGFR-MUTANT ADVANCED NSCLC AFTER DISEASE PROGRESSION ON OSIMERTINIB: PRIMARY RESULTS FROM THE PHASE III MARIPOSA-2 STUDY
Authors: A. Passaro, J. Wang, Y. Wang, S.-H. Lee, B. Melosky, J.-Y. Shih, J. Wang, K. Azuma, O. Juan-Vidal, M. Cobo, E. Felip, N. Girard, A.B. Cortot, R. Califano, F. Cappuzzo, S. Owen, S. Popat, J.-L. Tan, J. Salinas, P. Tomasini, R.D. Gentzler, W.N. William Jr., K.L. Reckamp, T. Takahashi, S. Ganguly, D.M. Kowalski, A. Bearz, M. MacKean, P. Barala, A.B. Bourla, A. Girvin, J. Greger, D. Millington, M. Withelder, J. Xie, T. Sun, S. Shah, B. Diorio, R.E. Knoblauch, J.M. Bauml, R.G. Campelo, B.C. Cho
Date of publication: 12/01/2024
ADJUNCTIVE PASCOLIZUMAB IN RIFAMPICIN-SUSCEPTIBLE PULMONARY TUBERCULOSIS: PROOF-OF-CONCEPT, PARTIALLY-RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-ESCALATION TRIAL
Authors: Nicholas I. Paton, Meera Gurumurthy, Qingshu Lu, Francesca Leek, Philip Kwan, Hiromi W. L. Koh, James Molton, Lalaine Mortera, Sullian Naval, Zamzurina Abu Bakar, Yong-Kek Pang, Lionel Lum, Tow Keang Lim, Gail B. Cross, Ganesh Lekurwale, Hyungwon Choi, Veonice Au, John Connolly, Martin Hibberd, Justin A. Green, Pascolizumab Tuberculosis Trial Team
Date of publication: 25/03/2024
IRON DEFICIENCY IN HEALTHY, TERM INFANTS AGED FIVE MONTHS, IN A PEDIATRIC OUTPATIENT CLINIC: A PROSPECTIVE STUDY
Authors: Nur Aida Adnan, Emer Breen, Chin Aun Tan, Crystal C. Wang, Muhammad Yazid Jalaludin, Lucy Chai See Lum
Date of publication: 23/01/2024
LIMOSILACTOBACILLUS REUTERI DSM 17938-CONTAINING INFANT FORMULAS AND THE ASSOCIATIONS WITH GASTROINTESTINAL TOLERANCE: A CROSS-SECTIONAL OBSERVATIONAL STUDY
Authors: Happy Tummy Consortium, Luca Lavalle, Nicolas Sauvageot, Colin Ivano Cercamondi, Ivana Jankovic, Delphine Egli, and Yvan Vandenplas
Date of publication: 19/01/2023
PEMBROLIZUMAB VERSUS PACLITAXEL FOR PREVIOUSLY TREATED ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER (KEYNOTE-063): A RANDOMIZED, OPEN-LABEL, PHASE 3 TRIAL IN ASIAN PATIENTS
Authors: Hyun Cheol Chung MD, PhD, Yoon-Koo Kang MD, PhD, Zhendong Chen MD, Yuxian Bai MD, Wan Zamaniah Wan Ishak MD, Byoung Yong Shim MD, Young Lee Park MD, Dong-Hoe Koo MD, PhD, Jianwei Lu MD, Jianming Xu MD, Hong Jae Chon MD, Li-Yuan Bai MD, Shan Zeng MD, Ying Yuan MD, Yen-Yang Chen MD, Kangsheng Gu MD, Wen Yan Zhong PhD, Shu Kuang MD, Chie-Schin Shih MD, Shu-Kui Qin MD, PhD
Date of publication: 08/12/2021
EFFICACY AND SAFETY OF THE ADDITION OF SITAGLIPTIN TO TREATMENT OF YOUTH WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL ON METFORMIN WITHOUT OR WITH INSULIN
Authors: Muhammad Yazid Jalaludin, Asma Deeb, Philip Zeitler, Raymundo Garcia, Ron S Newfield, Yulia Samoilova, Carmen A Rosario, Naim Shehadeh, Chandan K Saha, Yilong Zhang, Martina Zilli, Lynn W Scherer, Raymond L H Lam, Gregory T Golm, Samuel S Engel, Keith D Kaufman, R Ravi Shankar
Date of publication: 14/11/2021
A RANDOMIZED CLINICAL TRIAL OF THE EFFICACY AND SAFETY OF SITAGLIPTIN AS INITIAL ORAL THERAPY IN YOUTH WITH TYPE 2 DIABETES
Authors: R Ravi Shankar, Philip Zeitler, Asma Deeb, Muhammad Yazid Jalaludin, Raymundo Garcia, Ron S Newfield, Yulia Samoilova, Carmen A Rosario, Naim Shehadeh, Chandan K Saha, Yilong Zhang, Martina Zilli, Lynn W Scherer, Raymond L H Lam, Gregory T Golm, Samuel S Engel, Keith D Kaufman
Date of publication: 14/11/2021
A PHASE 3 TRIAL OF LUSPATERCEPT IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA
Authors: M. Domenica Cappellini, M.D., Vip Viprakasit, D.Phil., Ali T. Taher, M.D., Ph.D., Pencho Georgiev, M.D., Kevin H.M. Kuo, M.D., Thomas Coates, M.D., Ersi Voskaridou, M.D., Hong-Keng Liew, M.B., B.S., Idit Pazgal-Kobrowski, M.D., G.L. Forni, M.D., Silverio Perrotta, M.D., Abderrahim Khelif, M.D., Ashutosh Lal, M.D., Antonis Kattamis, M.D., Ph.D., Efthymia Vlachaki, M.D., Ph.D., Raffaella Origa, M.D., Yesim Aydinok, M.D., Mohamed Bejaoui, M.D., P. Joy Ho, M.B., B.S., D.Phil., Lee-Ping Chew, M.D., Ping-Chong Bee, M.D., Soo-Min Lim, M.D., Meng-Yao Lu, M.D., Adisak Tantiworawit, M.D., Penka Ganeva, M.D., Liana Gercheva, M.D., Ph.D., Farrukh Shah, M.B., B.S., Ellis J. Neufeld, M.D., Ph.D., Alexis Thompson, M.D., M.P.H., Abderrahmane Laadem, M.D., Jeevan K. Shetty, M.B., Ch.B.,, Jun Zou, M.D., Ph.D., Jennie Zhang, M.S., Dimana Miteva, Ph.D., Tatiana Zinger, Ph.D., Peter G. Linde, M.D., Matthew L. Sherman, M.D., Olivier Hermine, M.D., Ph.D., John Porter, M.D., and Antonio Piga, M.D., for the BELIEVE Investigators
Date of publication: 25/03/2020
LIRAGLUTIDE IN CHILDREN AND ADOLESCENTS WITH TYPE 2 DIABETES
Authors: William V. Tamborlane, M.D., Margarita Barrientos-PĂ©rez, M.M.S.C.I., Udi Fainberg, M.D., Helle Frimer-Larsen, M.Sc., Mona Hafez, M.D., Paula M. Hale, M.D., Muhammad Y. Jalaludin, M.D., Margarita Kovarenko, M.D., Ingrid Libman, M.D., Jane L. Lynch, M.D., Paturi Rao, Ph.D., Naim Shehadeh, M.D., et al., for the Ellipse Trial Investigators
Date of publication: 15/08/2019
ALTERED CIRCULATING CONCENTRATIONS OF ACTIVE GLUCAGON-LIKE PEPTIDE (GLP-1) AND DIPEPTIDYL PEPTIDASE 4 (DPP4) IN OBESE SUBJECTS AND THEIR ASSOCIATION WITH INSULIN RESISTANCE
Authors: Radwan H.Ahmed,Hasniza Zaman Huri, Sekaran Muniandy, Zaid Al-Hamodi, Boshra Al-absi, Abdulsamad Alsalahi, Muhammad FM Razif
Date of publication: 10/09/2017
P 019 – ALTERATIONS OF CULTURED MYOTUBES AND FASTING PLASMA METABOLITE PROFILES RELATED TO MITOCHONDRIAL DYSFUNCTION IN TYPE 2 DIABETES SUBJECTS
Authors: Mohamad Hafizi AbuBakar,HasnizaZaman Huri,Nany Hairunisa
Date of publication: 06/07/2017
STATIN THERAPY PRESCRIBING FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS: A REVIEW OF CURRENT EVIDENCE AND CHALLENGES
Authors: Mohamed Hassan Elnaem,1 Mohamad Haniki Nik Mohamed,1 Hasniza Zaman Huri,2 Shah M. Azarisman,3 and Ramadan Mohamed Elkalmi4
Date of publication: 01/06/2017
APOPTOTIC INDUCTION AND INHIBITION OF NF-ΚB SIGNALING PATHWAY IN HUMAN PROSTATIC CANCER PC3 CELLS BY NATURAL COMPOUND 2,2′-OXYBIS (4-ALLYL-1-METHOXYBENZENE), BISEUGENOL B, FROM LITSEA COSTALIS: AN IN VITRO STUDY
Authors: Abbaspour Babaei M, Zaman Huri H, Kamalidehghan B, Yeap SK, Ahmadipour F
Date of publication: 10/01/2017
RECEPTOR TYROSINE KINASE (C-KIT) INHIBITORS: A POTENTIAL THERAPEUTIC TARGET IN CANCER CELLS
Authors: Maryam Abbaspour Babaei,1 Behnam Kamalidehghan,2,3 Mohammad Saleem,4–6 Hasniza Zaman Huri,1,7 Fatemeh Ahmadipour1
Date of publication: 01/08/2016
CLINICAL AND GENETIC PREDICTORS OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR TREATMENT RESPONSE IN TYPE 2 DIABETES MELLITUS
Authors: Jazlina Liza Jamaluddin, Hasniza Zaman Huri & Shireene Ratna Vethakkan
Date of publication: 01/06/2016
GENETIC POLYMORPHISMS ASSOCIATED WITH OVERWEIGHT AND OBESITY IN UNCONTROLLED TYPE 2 DIABETES MELLITUS
Authors: Nor Bahirah Kasim, Hasniza Zaman Huri, Shireene Ratna Vethakkan, Luqman Ibrahim & Bashar Mudhaffar Abdullah
Date of publication: 21/03/2016
GENETIC MARKERS PREDICTING SULPHONYLUREA TREATMENT OUTCOMES IN TYPE 2 DIABETES PATIENTS: CURRENT EVIDENCE AND CHALLENGES FOR CLINICAL IMPLEMENTATION
Authors: Hasniza Zaman Huri, N K Loganadan, , S R Vethakkan & Z Hussein
Date of publication: 26/01/2016
A REVIEW ON BIOLOGICALLY ACTIVE N-MYRISTOYLATED HIV-1 NEF PROTEIN
Authors: Krisna Veni Balakrishnan, Bashar Mudhaffar Abdullah, Hasniza Zaman Huri, Nany Hairunisa and Narazah Mohd Yusoff
Date of publication: 29/10/2015
ANTITUMOR ACTIVITY FOR GOLD (III) COMPLEX BY HIGH CONTENT SCREENING TECHNIQUE (HCS) AND CELL VIABILITY ASSAY
Authors: Firas Hassan, Ayah Abdul Hameed, Ahemd Alshanon, Bashar Mudhaffar Abdullah, Hasniza Zaman Huri, Nany Hairunisa and Emad Yousif
Date of publication: 29/10/2015
UNRUPTURED SINUS OF VALSALVA ANEURYSM WITH RIGHT VENTRICULAR OUTFLOW TRACT OBSTRUCTION AND SUPRACRISTAL VENTRICULAR SEPTAL DEFECT: A RARE CASE
Authors: Ganiga Srinivasaiah Sridhar, Muhammad Athar Sadiq, Wan Azman Wan Ahmad, Chitra Supuramania, Timothy Watson, Imran Zainal Abidin, and Kok Han Chee
Date of publication: 01/10/2015
UNDER-RECOGNISED PERTUSSIS IN ADULTS FROM ASIAN COUNTRIES: A CROSS-SECTIONAL SEROPREVALENCE STUDY IN MALAYSIA, TAIWAN AND THAILAND. EPIDEMIOLOGY AND INFECTION. 2015 (IN PRESS)
A RANDOMISED TRIAL TO EVALUATE THE IMMUNOGENICITY, REACTOGENICITY, AND SAFETY OF THE 10-VALENT PNEUMOCOCCAL NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D CONJUGATE VACCINE (PHID-CV) CO-ADMINISTERED WITH ROUTINE CHILDHOOD VACCINES IN SINGAPORE AND MALAYSIA
Authors: Prof Dr Koh Mia Tuang(Department of Paediatrics-University of Malaya Medical Centre)
Date of publication: 02/10/2014
SAFETY AND IMMUNOGENICITY OF A TETRAVALENT DENGUE VACCINE IN HEALTHY CHILDREN AGED 2–11 YEARS IN MALAYSIA: A RANDOMIZED,PLACEBO-CONTROLLED, PHASE III STUDY
Authors: Prof. Dr. Koh Mia Tuang (Department of Paediatrics-University of Malaya Medical Centre)
Date of publication: 02/12/2013
IMPACT OF LEPTIN RECEPTOR GENE VARIANTS ON RISK OF NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS INTERACTION WITH ADIPONUTRIN GENE
Authors: Shamsul Mohd Zain,Zahurin Mohamed, Sanjiv Mahadeva, Phaik-Leng Cheah, Sanjay Rampal, Kin-Fah Chin, Anis Shafina Mahfudz, Roma Choudhury Basu, Hwa-Li Tan, Rosmawati Mohamed
Date of publication: 25/04/2013
SUSCEPTIBILITY AND GENE INTERACTION STUDY OF THE ANGIOTENSIN II TYPE 1 RECEPTOR (AGTR1) GENE POLYMORPHISMS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN A MULTI-ETHNIC POPULATION
Authors: Shamsul Mohd Zain,Zahurin Mohamed, Sanjiv Mahadeva, Sanjay Rampal, Roma Choudhury Basu, Phaik-Leng Cheah, Agus Salim, Rosmawati Mohamed
Date of publication: 06/03/2013
A MULTI-ETHNIC STUDY OF A PNPLA3 GENE VARIANT AND ITS ASSOCIATION WITH DISEASE SEVERITY IN NON-ALCOHOLIC FATTY LIVER DISEASE
Authors: Shamsul Mohd Zain,Rosmawati Mohamed,Sanjiv Mahadeva,Phaik Leng Cheah,Sanjay Rampal,Roma Choudhury Basu,Zahurin Mohamed
Date of publication: 19/01/2012
A PHASE III, MULTI-CENTRE, DOUBLE-BLIND, RANDOMISED STUDY TO ASSESS THE NON-INFERIORITY OF A COMMERCIAL LOT OF GLAXOSMITHKLINE (GSK) BIOLOGICALS’ 10-VALENT PNEUMOCOCCAL CONJUGATE (10PN-PD-DIT) VACCINE COMPARED TO A CLINICAL PHASE III VACCINE LOT, WHEN GIVEN AS A THREE-DOSE PRIMARY IMMUNIZATION COURSE.
Authors: Fong Seng Lim, Mia Tuang Koh, Kah Kee Tan, Poh Chong Chan, Chia Yin Chong, Yeo Wee Shung Yehudi, Yee Leong Teoh, Fakrudeen Shafi, Marjan Hezareh, Kristien Swinnen and Dorota Borys
Date of publication: 02/10/2014
